Jeff Geschwind, MD: Innovator in Drug Development A true innovator, Jeff Geschwind, MD, founded Cage Pharma. His research here is dedicated to creating novel cancer drugs that target tumor metabolism, specifically glycolysis, opening new avenues for treating aggressive and resistant cancers. https://medicine.yale.edu/news/medicineatyale/article/two-clinical-leaders-join-medical-school-as-administrators/